Timing of Blad-Care during BCG therapy for bladder cancer
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether giving Blad-Care early or later during BCG treatment changes outcomes for people with non-muscle-invasive bladder cancer. BCG is a standard therapy that uses a germ to help your immune system fight cancer, and Blad-Care is a device used in the bladder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older
- You have a type of bladder cancer that has not spread into the muscle layer of the bladder
- Your doctor has already said BCG therapy is right for you
- You have had a urine test that shows no infection before starting BCG
- You are not allergic to any part of the Blad-Care device
- You do not have a condition that makes BCG unsafe for you, like severe kidney problems or certain bladder issues
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a specific schedule of BCG (a weakened germ that boosts the immune system) placed directly into the bladder is safe and effective for medium- to high-risk bladder cancer that hasn't grown into the muscle. It aims to see if adjusting the standard BCG course can work better for people with a PD-L1-positive tumor.
This study is testing a way for people with early-stage bladder cancer to receive their BCG treatment at home, with extra support. It aims to see if doing treatment at home is safe and helpful for patients.
This trial studies whether bicalutamide can improve outcomes for people with non-muscle-invasive bladder cancer who are starting BCG through the bladder. It may help prevent cancer from coming back or progressing after BCG.
This trial tests whether changing your position while receiving BCG treatment (a liquid medicine placed directly into the bladder) can help it work better. You will wear a fitness tracker for a few days to monitor activity.
This study tries to predict whether BCG treatment will work for people with certain early-stage bladder cancers. It may help doctors better choose and monitor BCG for similar patients in the future.
This study looks at whether the bladder is ready to receive BCG, a medicine placed directly into the bladder, after surgeons remove a new bladder lesion. It may help doctors understand the best timing and preparation for BCG in early (non-muscle-invasive) bladder cancer.
Hear when a new Urinary Bladder Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.